SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-057096
Filing Date
2021-11-16
Accepted
2021-11-15 18:23:48
Documents
70
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 Q2 2022 10-Q qtnt-10q_20210930.htm   iXBRL 10-Q 2863230
2 EX-31.1 qtnt-ex311_9.htm EX-31.1 16408
3 EX-31.2 qtnt-ex312_7.htm EX-31.2 16435
4 EX-32.1 qtnt-ex321_6.htm EX-32.1 5157
5 EX-32.2 qtnt-ex322_10.htm EX-32.2 5135
  Complete submission text file 0001564590-21-057096.txt   9210479

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA qtnt-20210930.xsd EX-101.SCH 51744
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qtnt-20210930_cal.xml EX-101.CAL 61316
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qtnt-20210930_def.xml EX-101.DEF 201258
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE qtnt-20210930_lab.xml EX-101.LAB 422798
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qtnt-20210930_pre.xml EX-101.PRE 350032
11 EXTRACTED XBRL INSTANCE DOCUMENT qtnt-10q_20210930_htm.xml XML 1616967
Mailing Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA
Business Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA 41274832286
Quotient Ltd (Filer) CIK: 0001596946 (see all company filings)

IRS No.: 264719797 | State of Incorp.: Y9 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-36415 | Film No.: 211413221
SIC: 2835 In Vitro & In Vivo Diagnostic Substances